Evolving regulatory landscape across markets poses new set of challenges for generic players: ICRA
The near-term for the Indian pharma continues to be principally supported patent expiration wave in the US, strong product…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
CII Pharma Summit reflects issues on clinical trials
Explores how the industry can navigate through the regulatory challenges and chart its strategies for growth
Aptar Pharma unveils Pro-Ject technology platform
To provide optimal patient convenience and compliance
Suven Life secures two product patents from the US and Japan
The patents are valid through 2026 and 2028
Eisai starts supply of Diethylcarbamazine to eliminate lymphatic filariasis
First shipment to benefit more than 6 million people in four endemic countries
Piramal Enterprises acquires Caladryl brand in India
Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching
Glenmark’s consolidated revenue increases to Rs 14630.06 million for Q2 FY 13-14
Net profit for the second quarter was Rs 1542.97 million as compared to Rs 1567.52 million for the previous corresponding quarter
Narayana Health signs MoU with CSIR-Indian Institute of Chemical Biology Kolkata
To initiate translational research towards advanced therapeutics and diagnostics
IHS announces webinar on ‘Assessing Global Healthcare Market Access Risk ‘ on Nov 7,…
Express Pharma is the Strategic Media Partner
Torrent Pharmaceuticals records 25 per cent growth in revenues during Q2′ 13-14
Domestic formulation business recorded revenues of Rs 297 crores
Multisorb Technologies to exhibit solutions for pharmaceutical stability at MEDICA/COMPAMED 2013
To have experienced staff on hand to discuss its solutions for stabilising pharmaceutical, in-vitro diagnostic, medical device,…
Indoco’s sales and EBIDTA margins improve substantially
Posts total revenue growth of 24.8 per cent at Rs 2023 million
Lupin posts robust profits, sees consistent growth
Net sales up 18 per cent; EBITDA up 42 per cent and net profit up 40 per cent
Venus Remedies to launch Elores in Latin America next year
Expects to generate a revenue of $5 million within three years of the launch
Merck India provides solution to overcome counterfeiting
Helps in reducing health hazards and also increasing safety of consumers
Alembic Pharmaceuticals revenues up 20 per cent at Rs 488 crores for quarter ended September 30th,…
PBT up 52 per cent at Rs 80.49 crores
Wockhardt posts second quarter and first half results for the financial year 2014
The consolidated revenue for the quarter ended September 30 was Rs 1197 crore